$1.07
-0.16-13.01%
最終更新: Oct 30, 7:26 PM
Benzinga
Benzinga
Benzinga
土曜日, 10 31
Benzinga
© 2026 Benzinga | All Rights Reserved
Decoy Therapeutics (DCOY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-4.46 | $-2.88 | -54.9 % |
| Q1 | May 8, 2026 | $-4.18 | $-4.08 | -2.45 % |
| FY | Mar 31, 2026 | $-129.10 | $-12.96 | -896.1 % |
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | FY '25 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-2.88 | $-4.08 | $-12.96 |
| Actual | $-4.46 | $-4.18 | $-129.10 |
| Surprise | -54.9% | -2.45% | -896.1% |
| Revenue | |||
| Estimate | — | — | — |
| Actual | $227629 | $0 | $0 |
| Surprise | — | — | — |
| Metric | Q3 '26E | FY '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-2.59 | $-8.96 |
| Revenue | ||
| Consensus | — | — |